CNIO and CNIC find clues to clarify why cohesine has a role in cancer and cardiac development

August 11, 2020

Ana Losada, from the Spanish National Cancer Research Centre (CNIO), is the scientist who identified cohesin in vertebrates, a protein that is essential in cell division. Losada has studied cohesin since she identified it in vertebrates in 1998, at the Cold Spring Harbor Laboratory in New York. "It is fascinating," she says. "Now we know that cohesin plays a role in several types of cancer, and a large number of researchers worldwide have become greatly interested in this protein complex."

This week, Losada, Head of the Chromosome Dynamics Group at CNIO, is publishing a paper about her team's new finding on the role of cohesin in the high-impact journal Cell Reports. Co-authors are Paco Real, Head of the Epithelial Carcinogenesis Group at CNIO, and Miguel Manzanares, Head of the Functional Genomics Research Group at the Spanish National Centre for Cardiovascular Research (CNIC), currently at the Severo Ochoa Centre for Molecular Biology (CBMSO). Andrés Hidalgo, Head of the Imaging the Cardiovascular Inflammation and the Immune Response at CNIC has also participated in the study.

Cohesin has a role in chromosome segregation, forming a ring that "embraces" DNA. The classical image of a dividing cell shows the chromatids of duplicated chromosomes held together at the centromere forming an X. Cohesin holds the sister chromatids together in a bond that is dissolved at the end of the cell division process and in this way ensures their equal distribution to daughter cells.

Cohesin was first discovered in budding yeast, a single-cell microorganism. Losada identified it in an amphibian, the African clawed frog (Xenopus laevis), whose cohesin is similar to that of humans.

A new field of research was opened that has since then attracted the interest of several research teams worldwide. There is a lot to study in this field. Cohesin "has been evolutionarily conserved in very different species for millions of years, which means it has a very important role," Losada says.

Soon afterwards, other functions of cohesin were discovered. In addition to holding the two chromosome copies together until the daughter cells separate at the end of the cell division process, cohesin "participates in genome architecture, in DNA spatial organisation," Losada adds. Cohesin participates in the appropriate folding of chromosomes, which is essential for the information encoded in the genome to be read at the right moment and in the right cell types.

Approximately five years ago, mutations in genes encoding cohesin were identified in several types of cancer. In bladder cancer, for instance, cohesin mutations are very common, as found by the CNIO groups headed by Paco Real and Núria Malats. Furthermore, mutations in genes encoding cohesin and its regulators are associated with rare diseases known as cohesinopathies. These findings have attracted the interest of more research groups worldwide.

Currently, Losada is no longer studying frogs but mice, the main animal model at CNIO. Her study throws light on the mechanisms of cohesin function and what happens when it does not work properly.

"Actually, cohesin is a protein complex made of multiple subunits," Losada explains. "Cells have two versions of this complex; one of them carries the STAG1 subunit, and the other, the STAG2 subunit. Although they are similar, they are not identical, so we want to understand why they are there, what they do and what the consequences are if the cell loses one or the other."

Essential in embryos, nonessential in adults

The answers to these questions motivated by curiosity will most probably help scientists understand the biology of cancer and other diseases.

In the new article published in Cell Reports, Losada, Real and Manzanares report the generation of a mouse model where they were able to inactivate the STAG2 subunit in different development stages, including the adult stage. They found that STAG2 was mostly nonessential in adult animals: its inactivation in all tissues did not cause tumours, but was detrimental to the health of the animals.

In embryos, however, STAG2 is essential. This means that embryos lacking STAG2 die before birth; their overall development is delayed, and they show severe defects in cardiac development.

The finding may seem just a small puzzle piece, but it will probably help scientists understand the functioning of cells and organisms better. "Our results provide substantial evidence of the specific functions performed by the different subunits of the cohesin complex in different cells and tissues and how their malfunction is associated with disease," the authors of the article add.
-end-
The study was funded by the Spanish Ministry of Science and Innovation, the Institute of Health Carlos III, the Spanish State Research Agency, the European Regional Development Fund, the Spanish Association Against Cancer (AECC), and the Pro CNIC Foundation.

Reference article:Essential roles of cohesin STAG2 in mouse embryonic development and adult tissue homeostasis. Magali De Koninck, Eleonora Lapi, Claudio Badía-Careaga, Itziar Cossío, Daniel Giménez-Llorente, Miriam Rodríguez-Corsino, Elena Andrada, Andrés Hidalgo, Miguel Manzanares, Francisco X. Real, Ana Losada (Cell Reports, 2020). DOI: 10.1016/j.celrep.2020.108014

Centro Nacional de Investigaciones Oncológicas (CNIO)

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.